Devices · For physicians
Focused vs Radial Extracellular Shockwave Therapy for AVN
Published October 16, 2026
- Focused Penetration Depth
- Up to 10-12 cm
- Typical Treatment Cadence
- 3-5 Sessions
- Primary Cost Drivers
- Applicator Lifespan & Focal Applicator Heads
Capable of delivering targeted energy flux density to deep subchondral structures like the femoral head.
Standard clinical protocol spaced 7 to 14 days apart for osseous tissue remodeling.
Operational costs stem from pulse-count head replacements and specialized depth stand-offs.
When comparing focused vs radial extracellular shockwave therapy for avascular necrosis, focused acoustic shockwaves are required to reach deep subchondral bone, as radial pressure waves dissipate in superficial soft tissues before reaching necrotic femoral lesions. Focused systems deliver precise, high-density focal energy directly to deep osseous structures to promote local neovascularization and tissue remodeling. Clinical teams evaluating capital /devices can review depth parameters, treatment protocols, and practice integration strategies to optimize outcomes for deep bone pathologies.
Acoustic Physics and Penetration Mechanics
Understanding the physical principles of acoustic wave generation is critical when selecting shockwave modalities for deep tissue bone pathologies. While both technologies are utilized in musculoskeletal medicine, their wave formation, focal zones, and energy transmission profiles differ fundamentally.
Focused Shockwave Therapy (fESWT)
Focused shockwaves are true acoustic shockwaves characterized by a rapid rise time (less than 10 nanoseconds), high peak pressure (frequently exceeding 50 to 100 MPa), and a short pulse duration. Generated via electrohydraulic, electromagnetic, or piezoelectric mechanisms, fESWT converges energy at a specific, adjustable focal point deep within body tissues.
This convergent acoustic field allows high energy flux density ($mJ/mm^2$) to pass through cutaneous and subcutaneous layers with minimal dispersion, delivering therapeutic mechanical stress directly to subchondral bone, the femoral head, or the talus.
Radial Pressure Wave Therapy (rESWT)
Radial pressure waves—often categorized alongside extracellular shockwave modalities—are pneumatic pressure waves generated by accelerating a projectile with compressed air against a transmitter head. Unlike true shockwaves, radial waves exhibit a slow rise time, significantly lower peak pressures (typically 0.1 to 5 MPa), and maximum energy density directly at the applicator surface.
As radial energy penetrates tissue, it diverges exponentially according to the inverse-square law. By a depth of 3 to 4 centimeters, energy density drops below levels capable of triggering osseous remodeling, making radial devices unsuitable as a monotherapy for deep avascular necrosis (AVN).
Focused vs Radial Shockwave Therapy for Avascular Necrosis
When treating early-stage osteonecrosis (Ficat and Arlet Stage I and II), clinical utility depends on matching penetration characteristics to lesion depth and biological requirements.
- Target Depth Capability: Focused systems penetrate up to 10 to 12 centimeters with tailored focal zone stand-offs, easily reaching deep hip, knee, or ankle joint structures. Radial systems dissipate energy within 2 to 4 centimeters of the skin surface.
- Energy Density at Target Site: Focused shockwaves maintain therapeutic energy flux densities ($0.15 - 0.40 mJ/mm^2$) at deep target sites without damaging overlying soft tissues. Radial pressure waves lose structural intensity prior to reaching subchondral bone.
- Biological Mechanism in Bone: Focused acoustic pulses generate micro-cavitation and controlled mechanical shear stress within necrotic bone zones, upregulating vascular endothelial growth factor (VEGF), vessel-endothelial nitric oxide synthase (eNOS), and proliferating cell nuclear antigen (PCNA). Radial waves generate superficial mechanical stress best suited for tendinopathies and myofascial trigger points.
- Clinical Goal in AVN: Focused therapy aims to stimulate neo-vascularization, resorb subchondral necrotic bone, and promote osteogenesis to prevent joint surface collapse. Radial therapy functions primarily as a supportive tool to treat surrounding secondary muscular guarding and superficial bursitis.
Clinicians seeking to build advanced non-surgical orthopedic protocols can explore specialized acoustic platforms within our regenerative device portfolio.
Mechanotransduction and Biological Response in Osseous Tissue
Avascular necrosis results from impaired microvascular circulation leading to osteocyte apoptosis and trabecular architecture collapse. Reversing or halting this process requires mechanotransduction—the conversion of mechanical sound signals into cellular biochemical activity.
Focused shockwaves induce micro-trauma at the interface between necrotic and viable trabecular bone without disrupting structural integrity. This mechanical stimulus triggers an immediate inflammatory cascade followed by structural tissue remodeling:
- Angiogenesis and Revascularization: Upregulation of VEGF and basic fibroblast growth factor (bFGF) stimulates capillary sprouting from surrounding healthy bone margins into the ischemic zone.
- Osteogenesis: Acoustic stress promotes osteoblast differentiation while regulating osteoclast activity, encouraging the replacement of necrotic bone with newly synthesized lamellar bone.
- Analgesic Response: High-energy acoustic waves hyper-stimulate nociceptors and alter local substance P levels, providing functional pain reduction during bone remodeling.
For clinical practices managing complex musculoskeletal cases, combining energy modalities with targeted biological protocols often optimizes patient management strategies. Learn more about complementary biologic options on our biologics platform.
Operational and Financial Considerations for Practice Managers
From a practice procurement and operational workflow perspective, evaluating focused versus radial systems involves analyzing capital expenditures, consumable costs, staffing rules, and clinical efficiency.
Capital Investment and Equipment Selection
Focused shockwave units require higher capital investment due to precise high-voltage or piezoelectric pulse generators and adjustable focal applicators. Radial units carry lower initial device costs and simple maintenance cycles. However, substituting a radial device for deep bone pathology yields suboptimal clinical results and risks treatment failure in AVN cases.
Staffing and Delegation
In many state jurisdictions, applying focused shockwave therapy to deep joint structures or subchondral bone is restricted to licensed physicians, physician assistants, or nurse practitioners. Radial pressure wave applications for superficial tendinopathies may, where permitted by state medical boards, be delegated to clinical staff or physical therapists under supervision. Practices adding focused modalities should plan physician time accordingly.
Treatment Protocols and Clinic Throughput
Typical fESWT protocols for osteonecrosis consist of 3 to 5 treatments spaced 1 to 2 weeks apart. Each session requires 2,000 to 4,000 pulses, taking approximately 15 to 20 minutes of dedicated clinical room time. Integrating this technology allows practices within orthopedics and sports medicine to offer non-invasive alternatives prior to surgical joint replacement.
What This Means for Your Practice
Integrating focused extracellular shockwave therapy for avascular necrosis enables clinics to expand non-surgical treatment options for early-stage joint conditions:
- Establish Diagnostic Protocols: Utilize MRI and plain radiography to accurately stage AVN (Ficat & Arlet Stage I/II). Target focused shockwave energy precisely to the ischemic lesion.
- Select True Focused Technology: Verify that prospective shockwave platforms utilize electromagnetic, electrohydraulic, or piezoelectric sources capable of delivering adequate energy density to depths exceeding 8 cm.
- Differentiate Modality Applications: Reserve radial pressure wave devices for superficial soft tissue pathologies and utilize focused systems for bone remodeling and vascular restoration.
- Educate Clinical Staff: Train operational and clinical teams on proper coupling techniques, focal depth adjustments, patient positioning, and post-treatment follow-up schedules.
To discuss technology acquisition, operational integration, or clinical training for focused shockwave systems, contact Dallas Regenerative Solutions to consult with our medical device specialists.
Frequently asked questions
- Why is radial shockwave ineffective for treating deep avascular necrosis?
- Radial pressure waves dissipate energy maximums near the skin surface, with energy density decaying exponentially within 2 to 4 centimeters. Deep bony structures like the femoral head require focused shockwaves that concentrate energy at depths up to 10-12 centimeters without causing cutaneous damage.
- What stages of avascular necrosis respond best to focused shockwave therapy?
- Focused shockwave therapy is most effective in early-stage avascular necrosis (Ficat and Arlet Stage I and Stage II) prior to structural subchondral collapse. Once structural articular collapse occurs (Stage III/IV), non-surgical energy therapies become palliative rather than regenerative.
- Can radial and focused shockwaves be used together in a single treatment plan?
- Yes. Clinicians often utilize focused shockwaves to treat the deep osseous lesion and underlying avascular bone while applying radial pressure waves to surrounding soft tissues to address secondary muscle guarding and superficial tendinopathies.
- What credentialing is required to administer focused shockwave therapy for AVN?
- Because focused shockwave targets deep subchondral bone structures and delivers high energy flux densities, state regulations typically require administration by a licensed physician, physician assistant, or nurse practitioner with specialized training.
